Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Game-Based Versus Linear Sprint Training in Male Soccer Players (GBS-LST)

28 de agosto de 2026 actualizado por: Görkem Açar, Istanbul Gelisim University

A 12-Week Randomized Controlled Trial Evaluating the Time-Course Effects of Once-Weekly Game-Based Versus Linear Sprint Training on Soccer Performance and Hamstring Strength in Amateur Players During the Competitive Season

This randomized controlled trial investigated the effects of two different sprint training approaches on physical performance in male amateur soccer players during the competitive season. The study aimed to determine whether once-weekly game-based sprint training or linear sprint training could improve sprint performance, change-of-direction ability, hamstring strength, and maximum running velocity achieved during official matches.

Thirty-six male amateur soccer players were randomly assigned in a 1:1:1 ratio to one of three groups: the Game-Based Sprint Group, the Linear Sprint Group, or the Control Group. Participants in both sprint training groups completed one additional sprint training session per week for 12 weeks while continuing their regular soccer training and competition schedule. The Linear Sprint Group performed maximal 40-meter linear sprints, whereas the Game-Based Sprint Group performed soccer-specific sprint activities that included running, ball involvement, and technical actions. The Control Group continued regular soccer training without an additional sprint-specific intervention.

Sprint performance, change-of-direction performance, and right and left hamstring strength were assessed at baseline, Week 6, and Week 12. Maximum running velocity was also monitored during official matches throughout the 12-week study period. The study was designed to compare how the two sprint training approaches affected performance over time and whether changes observed during standardized testing were also reflected in maximum running velocity during competitive matches.

Descripción general del estudio

Estado

Terminado

Condiciones

Intervención / Tratamiento

Tipo de estudio

Intervencionista

Inscripción (Actual)

36

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Istanbul
      • Istanbul, Istanbul, Turquía (Türkiye), 34310
        • Istanbul Gelisim University

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion Criteria:

  • Male amateur-licensed soccer players.
  • A minimum of 5 years of regular soccer training experience.
  • Participation in organized soccer training at least 5 days per week.

Exclusion Criteria:

  • A serious musculoskeletal injury within the previous 6 months that could interfere with participation in the training intervention or performance assessments.
  • Musculoskeletal surgery within the previous 6 months that could interfere with the study outcomes.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Linear Sprint Group (LSG)
Participants performed maximal 40-m linear sprint training once weekly on M-3 (Wednesday), approximately 72 hours before the official match, in addition to their regular soccer training. The 12-week intervention was progressively structured across three four-week phases.
Participants performed maximal 40-m linear sprints once weekly for 12 weeks. During Weeks 1-4, participants completed 2 sets of 4 repetitions with 90 seconds of recovery between repetitions and 3 minutes between sets. During Weeks 5-8, they completed 3 sets of 4 repetitions with the same recovery periods. During Weeks 9-12, they completed 3 sets of 5 repetitions with 90 seconds of recovery between repetitions and 4 minutes between sets. The intervention was performed in addition to regular soccer training.
Experimental: Game-Based Sprint Group (GBSG)
Participants performed game-based sprint training once weekly on M-3 (Wednesday), approximately 72 hours before the official match, in addition to their regular soccer training. Training consisted of soccer-specific maximal sprint actions within a standardized crossing-and-shooting drill incorporating ball involvement, perceptual demands, and technical actions. The 12-week intervention was progressively structured across three four-week phases.
Participants performed soccer-specific maximal sprint actions within a standardized crossing-and-shooting drill once weekly for 12 weeks. During Weeks 1-4, participants completed 2 sets of 4 repetitions of 8-10-second contextual sprint actions, with 90 seconds of recovery between repetitions and 3 minutes between sets. During Weeks 5-8, they completed 3 sets of 4 repetitions using the same sprint duration and recovery periods. During Weeks 9-12, they completed 3 sets of 5 repetitions of 10-12-second contextual sprint actions, with 90 seconds of recovery between repetitions and 4 minutes between sets. The drills incorporated ball involvement, perceptual demands, and soccer-specific technical actions.
Sin intervención: Control Group (CG)
Participants continued their regular competitive-season soccer training and match schedule throughout the 12-week study period without receiving any additional sprint-specific intervention.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
40-m Sprint Performance
Periodo de tiempo: Baseline (Week 0), Week 6, and Week 12
The time required to complete a 40-m maximal linear sprint was measured using the SmartSpeed electronic timing system (VALD Performance, Australia). Participants completed two maximal trials, and the fastest time was retained for analysis. Lower values indicate better sprint performance.
Baseline (Week 0), Week 6, and Week 12

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
T-Drill Change-of-Direction Performance
Periodo de tiempo: Baseline (Week 0), Week 6, and Week 12
Change-of-direction performance was assessed using the T-drill test. Participants completed two maximal trials, and the fastest completion time was retained for analysis. Lower values indicate better performance.
Baseline (Week 0), Week 6, and Week 12
Hamstring Strength
Periodo de tiempo: Baseline (Week 0), Week 6, and Week 12
Bilateral hamstring strength was assessed using the NordBord system (VALD Performance). Right and left limbs were assessed separately, with force recorded in Newtons (N). Participants completed two maximal-effort trials for each limb, and the highest value was retained for analysis.
Baseline (Week 0), Week 6, and Week 12
Match Maximum Running Velocity
Periodo de tiempo: During official matches throughout the 12-week intervention period
Maximum running velocity during official soccer matches was monitored using the Catapult S7 GPS system. The highest running velocity achieved by each participant during each official match was retained for analysis.
During official matches throughout the 12-week intervention period

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de noviembre de 2025

Finalización primaria (Actual)

24 de enero de 2026

Finalización del estudio (Actual)

24 de enero de 2026

Fechas de registro del estudio

Enviado por primera vez

28 de agosto de 2026

Primero enviado que cumplió con los criterios de control de calidad

28 de agosto de 2026

Publicado por primera vez (Actual)

2 de septiembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

2 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

28 de agosto de 2026

Última verificación

1 de agosto de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • SPRINT-RCT-2025-397267

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .